This is the library for the enduring materials from the Targets in Cancer IO: A Deep Dive, Targeted Systemic Delivery of Innate Immune Activators webinar that took place on August 26, 2022.
Moderators:
Faculty:
Targets for Cancer IO: A Deep Dive Series 2 is supported, in part, by educational grants from Genmab, US, Inc. Iovance Biotherapeutics, and Merck & Co., Inc. (as of 7/26/2022).Interested in supporting this program? The SITC Development team would love to work with you. Contact Development@sitcancer.org for more information on how your organization's support can help advance cancer immunotherapy and make "cure" a reality.
Meeting: 2022 Targets for Cancer IO: A Deep Dive, Targeted systemic delivery of innate immune activators; Presenter: Timothy Lowinger, PhD – Mersana Therapeutics; Date: August 26, 202200:31:06
Meeting: 2022 Targets for Cancer IO: A Deep Dive, Targeted systemic delivery of innate immune activators; Presenter: Trevor Hallam, PhD – Sutro Biopharma; Date: August 26, 202200:28:39
Meeting: 2022 Targets for Cancer IO: A Deep Dive, Targeted systemic delivery of innate immune activators; Presenter: Valerie Odegard, PhD – Silverback Therapeutics; Date: August 26, 202200:26:47